The analysis of therapeutic effect of primary liver cancer treated by Aidi injection combined with stereotactic radiotherapy
Objective To analyze the therapeutic effect of primary liver cancer treated by Aidi injection combined with stereotactic radiotherapy SRT. Methods 50 patients with primary liver cancer were treated with X-ray SRT, and 57 patients were treated with Aidi injection combined with SRT,SRT:DT 40～60 Gy(300～400 cGy/F,3F/w, Aidi injection 60ml+ NS/5%GS 500ml,dl～dl4,the second course line spacing 10 days. Results All patients were examined with image of CT or MRI. The total effective rate(CR+PR),the disease control rate (DCR) and 1,2,3 years survival rates was 75. 5%,94. 7% vs 72%,92% and 65%,29. 8%,10. 5% VS 56%.22%, 8%, There were no differences in curative effect and survival rates( P>0.05). Bone marrow restrain incidence and life for the total effective rate was ignificantlys sever in Aidi group than in SRT group ( 22. 8%vs42% and 73. 7% vs 52%) (P< 0.05). Conclusions Aidi injection combined with SRT in the treatment of primary liver cancer can resist radiation and improve patients quality of life.
NETL
NSTL
万方数据
维普
